Schmidt H, Zhang M, Chakarov D, Bansal V, Mourelatos H, Sanchez-Rivera F
Genome Biol. 2025; 26(1):41.
PMID: 40011959
PMC: 11863968.
DOI: 10.1186/s13059-025-03488-8.
Whalen J, Earley J, Wisniewski C, Mercurio A, Cantor S
Nat Cancer. 2025; 6(2):278-291.
PMID: 39838098
DOI: 10.1038/s43018-024-00902-1.
Harper N, Birdsall G, Honeywell M, Pai A, Lee M
bioRxiv. 2024; .
PMID: 39713309
PMC: 11661175.
DOI: 10.1101/2024.12.09.627542.
Lim A, Pouyabahar D, Ashraf M, Huang K, Lohbihler M, Murareanu B
Nat Commun. 2024; 15(1):10206.
PMID: 39604360
PMC: 11603134.
DOI: 10.1038/s41467-024-54337-4.
Lam S, Thomas J, Jackson S
Genome Med. 2024; 16(1):139.
PMID: 39593080
PMC: 11590575.
DOI: 10.1186/s13073-024-01414-4.
Genome-wide screening reveals essential roles for HOX genes and imprinted genes during caudal neurogenesis of human embryonic stem cells.
Kinreich S, Bialer-Tsypin A, Viner-Breuer R, Keshet G, Suhler R, Lim P
Stem Cell Reports. 2024; 19(11):1598-1619.
PMID: 39486407
PMC: 11589199.
DOI: 10.1016/j.stemcr.2024.09.009.
Parallel genome-scale CRISPR-Cas9 screens uncouple human pluripotent stem cell identity versus fitness.
Rosen B, Li Q, Cho H, Liu D, Yang D, Graff S
Nat Commun. 2024; 15(1):8966.
PMID: 39419994
PMC: 11487130.
DOI: 10.1038/s41467-024-53284-4.
Genome-Wide CRISPR Screen Identifies KEAP1 Perturbation as a Vulnerability of ARID1A-Deficient Cells.
Fournier L, Kalantari F, Wells J, Lee J, Trigo-Gonzalez G, Moksa M
Cancers (Basel). 2024; 16(17).
PMID: 39272807
PMC: 11394604.
DOI: 10.3390/cancers16172949.
GNAS knockout potentiates HDAC3 inhibition through viral mimicry-related interferon responses in lymphoma.
He M, Tong K, Liu T, Whittaker Hawkins R, Shelton V, Zeng Y
Leukemia. 2024; 38(10):2210-2224.
PMID: 39117798
PMC: 11436380.
DOI: 10.1038/s41375-024-02325-4.
The interferon γ pathway enhances pluripotency and X-chromosome reactivation in iPSC reprogramming.
Barrero M, Lazarenkov A, Blanco E, Palma L, Lopez-Rubio A, Bauer M
Sci Adv. 2024; 10(32):eadj8862.
PMID: 39110794
PMC: 11305397.
DOI: 10.1126/sciadv.adj8862.
Functional genomics reveals an off-target dependency of drug synergy in gastric cancer therapy.
Leylek O, Honeywell M, Lee M, Hemann M, Ozcan G
Gastric Cancer. 2024; 27(6):1201-1219.
PMID: 39033209
PMC: 11513712.
DOI: 10.1007/s10120-024-01537-y.
Genome-scale CRISPR-Cas9 screening in stem cells: theories, applications and challenges.
Zhou H, Ye P, Xiong W, Duan X, Jing S, He Y
Stem Cell Res Ther. 2024; 15(1):218.
PMID: 39026343
PMC: 11264826.
DOI: 10.1186/s13287-024-03831-z.
Phenotypic targeting using magnetic nanoparticles for rapid characterization of cellular proliferation regulators.
Wang Z, Wang H, Lin S, Angers S, Sargent E, Kelley S
Sci Adv. 2024; 10(19):eadj1468.
PMID: 38718125
PMC: 11078187.
DOI: 10.1126/sciadv.adj1468.
Loss of NEDD8 in cancer cells causes vulnerability to immune checkpoint blockade in triple-negative breast cancer.
Papakyriacou I, Kutkaite G, Rubies Bedos M, Nagarajan D, Alford L, Menden M
Nat Commun. 2024; 15(1):3581.
PMID: 38678024
PMC: 11055868.
DOI: 10.1038/s41467-024-47987-x.
Lethal phenotypes in Mendelian disorders.
Cacheiro P, Lawson S, Van den Veyver I, Marengo G, Zocche D, Murray S
Genet Med. 2024; 26(7):101141.
PMID: 38629401
PMC: 11232373.
DOI: 10.1016/j.gim.2024.101141.
Lethal phenotypes in Mendelian disorders.
Cacheiro P, Lawson S, Van den Veyver I, Marengo G, Zocche D, Murray S
medRxiv. 2024; .
PMID: 38260283
PMC: 10802756.
DOI: 10.1101/2024.01.12.24301168.
Untangling the Context-Specificity of Essential Genes by Means of Machine Learning: A Constructive Experience.
Giordano M, Falbo E, Maddalena L, Piccirillo M, Granata I
Biomolecules. 2024; 14(1).
PMID: 38254618
PMC: 10813179.
DOI: 10.3390/biom14010018.
Abrogation of the G2/M checkpoint as a chemosensitization approach for alkylating agents.
Lang F, Cornwell J, Kaur K, Elmogazy O, Zhang W, Zhang M
Neuro Oncol. 2023; 26(6):1083-1096.
PMID: 38134889
PMC: 11145461.
DOI: 10.1093/neuonc/noad252.
Functional genomics reveals an off-target dependency of drug synergy in gastric cancer therapy.
Leylek O, Honeywell M, Lee M, Hemann M, Ozcan G
bioRxiv. 2023; .
PMID: 37873383
PMC: 10592690.
DOI: 10.1101/2023.10.07.561351.
Genome-Wide CRISPR Screens Identify Multiple Synthetic Lethal Targets That Enhance KRASG12C Inhibitor Efficacy.
Mukhopadhyay S, Huang H, Lin Z, Ranieri M, Li S, Sahu S
Cancer Res. 2023; 83(24):4095-4111.
PMID: 37729426
PMC: 10841254.
DOI: 10.1158/0008-5472.CAN-23-2729.